← Back to Search

Cell Saver for Chronic Low Back Pain

N/A
Waitlist Available
Led By Mladen Djurasovic, MD
Research Sponsored by Norton Leatherman Spine Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-operative, range of 1 to 14 days
Awards & highlights

Study Summary

The purpose of this study is to determine the cost-effectiveness of using a cell saver for 2 to 3 level lumbar fusions. A secondary objective is to determine if there will be a decrease in the number of allogenic blood transfusions when a cell saver is used intraoperatively. Another secondary objective is to determine incidence of complications associated with cell saver use and transfusions.

Eligible Conditions
  • Chronic Low Back Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-operative, range of 1 to 14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-operative, range of 1 to 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Volume of blood transfused
Secondary outcome measures
Immediate post-op Hematocrit level
Immediate post-op Hemoglobin level

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Cell SaverActive Control1 Intervention
Patients will have the use of a cell-saver during surgery
Group II: No Cell saverPlacebo Group1 Intervention
Patient will not have cell saver available during surgery.

Find a Location

Who is running the clinical trial?

Norton Leatherman Spine CenterLead Sponsor
5 Previous Clinical Trials
537 Total Patients Enrolled
Mladen Djurasovic, MDPrincipal InvestigatorNorton Leatherman Spine Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~18 spots leftby Apr 2025